We previously reported that methicillin-resistant S. aureus (MRSA) acquired multidrug-resistance by chromosomal mutations that included mutations in norA, and that such strains were widespread. 8) To study the mechanism of development of multidrug-resistant S. aureus, we examined the frequency of generation of mutants during selection with various antiseptics and FQs and analyzed the sites of mutations in norA, gyrA and grlA by DNA sequencing. 2) MATERIALS AND METHODS Bacterial Strains, Media and Antimicrobial Agents S. aureus RN2677 was used as the parent strain 8) and Escherichia coli DH5a was used as the host for cloning of norA gene. Trypto-soy medium (Eiken Chemical Co., Ltd., Tokyo, Japan) and Mueller-Hinton medium (Difco Laboratory, Detroit, MI, U.S.A.) were used for normal growth of S. aureus and for susceptibility tests, respectively. E. coli was cultured in LB medium. The antiseptics included two dyes, [acriflavin (AF) and acrinol (AN)], two quaternary ammonium compounds, [benzethonium chloride (BTC) and benzalkonium chloride (BKC)], chlorhexidine digluconate (CHG) as an example of a biguanide compound and the two FQs, [norfloxacin (NFLX) and ofloxacin (OFLX; a gift from Daiichi Pharmaceutical Co. Ltd., Tokyo)].
Isolation of Mutants Spontaneous multidrug-resistant mutants of RN2677 were selected by plating 200 ml of overnight culture that was concentrated 10-fold (approximately 10 10 cfu/ml) onto trypto-soy agar plates with serial twofold-diluted concentrations of each agent and then incubating the plates at 37°C for 24 h. The frequency of generation of mutants was calculated from the number of colonies that grew on plates with and without a particular selective agent.
Antibacterial Susceptibility The minimum inhibitory concentrations (MICs) were determined by an agar doubledilution method.
9) An overnight bacterial culture was diluted 100-fold (to approximately 10 6 cfu/ml) and 5-ml aliquots of the suspension were spotted on agar plates prepared with each agent. The MICs were determined after overnight culture at 37°C. The threshold of low-level and high-level resistance to AF was defined as 100 mg/ml of MIC. 8) DNA Manipulation and Sequencing All DNA manipulations were performed as described previously. 8, 10) Table 1 shows the nucleotide sequences of the primers used to amplify the norA gene and the quinolone-resistance-determing regions (QRDRs) of the grlA and gyrA genes. The frequency of generation of multidrug-resistant mutants of Staphylococcus aureus was examined by selection with various antiseptics and fluoroquinolones and the mutated genes were characterized. Multidrug-resistant mutants with mutation of the region between the promoter and structural regions of the norA gene were generated more frequently during selective pressure with antiseptics than during selective pressure with FQs. We also obtained evidence for the existence of at least one other gene related to resistance to antiseptics and fluoroquinolones on the chromosome of S. aureus in addition to norA gene.
11)

Northern Blotting and Primer Extension Analysis
Key words Staphylococcus aureus; multidrug-resistant mutant; fluoroquinolone; antiseptic; norA 6) sis were performed as described previously, 12) using primer norA-PE. The 590 bp fragment that was amplified with primers norAϩ2 and norAϪ5 was used as the probe for the norA transcript. Northern blotting and probe labeling were performed as described previously. 10) RESULTS AND DISCUSSION Table 2 summarizes the frequencies of generation of mutants by selection with various antimicrobial agents. The frequency of generation of mutant by selection with AF and AN, the two dyes, was clearly higher than that by selection with the antiseptics and FQs. We randomly selected a total of 95 mutants and determined the MICs of antiseptics and FQs for each mutant. All mutants tested exhibited reduced susceptibilities to all antimicrobial agents tested. For genetic characterization of the mutant, we selected a further 22 mutants among the strains for which MICs were determined; the MICs for these 22 mutants are shown in Table 3 . Mutants (nϭ71/95) that exhibited low-level resistance and high-level resistance (MIC: Ն100 mg/ml) to AF were obtained by selection with dyes and quaternary ammonium compounds. However, mutants (nϭ24/95) obtained by selection with CHG and FQs exhibited low-level resistance to AF. Since all mutants tested exhibited reduced susceptibility to NFLX, we analyzed the nucleotide sequences of the norA gene and the QRDRs of the grlA and gyrA genes in the 22 selected mutants.
To determine the sequence of the norA gene (norA2677) in the parent strain RN2677, we cloned the norA2677 gene in E. coli. The PCR primers for amplification of norA2677 were designed based on the sequence of the norA2677 gene (Table  1) . We analyzed the norA genes from 22 mutants and the sites of mutations are shown in Table 3 . No mutations were 1130 Vol. 25, No. 9 found in the structural region of the norA gene and in the QRDR of the gyrA gene in the analyzed mutants. Six mutants (TP171, TP172, TP176, TP178, TP180, TP185) with high-level resistance to AF had mutations upstream of the structural region of the norA gene and could be classified into three types by reference to the site of the mutation (Table 3 , Fig. 1 ). Each mutation was located in the norA promoter, 13) with the exception of the mutation in TP178, which was located in the 5Ј untranslated region. To determine whether norA transcription might be altered by the various mutations, we examined the site of initiation of transcription and the level of norA transcripts in five norA mutants (TP171, TP172, TP176, TP180, TP185) (Figs. 2, 3) . The transcription initiation sites in all five mutants were identical to those previously reported (Fig. 2) . 13, 14) The level of norA transcripts was markedly higher in the five norA mutants than that in the parent strain, RN2677 (Fig. 3) . The results strongly suggested that the multidrug-resistance of five norA mutants, which each harbored a mutation in the norA promoter region, was due to increased transcription of norA. In the mutant TP178, the site of norA mutation was identical to that in the MT23142 mutant with a flqB mutation and the SA1199B mutant. 3, 13) Fournier et al. suggested that the flqB mutation (T→G) confers an altered mRNA secondary structure that protects a putative cleavage site of RNase III and lead to increased norA mRNA stability. 13) However, the norA mutations in the TP178 (T→C) and SA-1199B (T→A) mutants differ from the flqB mutation. 4, 5) Further studies are necessary to elucidate the mechanism of increased norA expression in the TP178 and SA1199B mutants.
Mutants with a wild-type norA gene were obtained by selection with antiseptics and FQs and all of these mutants exhibited low-level resistance to AF. Of these, mutants that were obtained by selection with antiseptics exhibited slightly reduced susceptibility to NFLX and OFLX. However, these mutants exhibited no mutations in the norA promoter and in the QRDRs in the grlA and gyrA genes, as was the case for mutant obtained previously. 15) These results therefore indicate the existence of another gene(s) on the S. aureus chromosome, in addition to norA, that is related to multidrug-resistance.
In contrast, mutants obtained by selection with FQs were resistant to FQs and, with the exception of TP189, all exhibited alterations in the QRDR of the grlA gene. The susceptibility of TP189 to antiseptics and FQs were similar to that of other mutants that were obtained by selection with FQs. Therefore, the mutation in TP189 might have occurred outside the sequenced region of grlA. In addition, mutants carrying a grlA mutation exhibited slightly reduced susceptibility to the antiseptics tested. More detailed studies are required to determine whether mutations in grlA affect susceptibility of antiseptics.
No mutants with mutations in the norA gene, which was identified as a norfloxacin-resistance gene in S. aureus, were obtained by selection with FQs, but norA mutants were generated by selection with antiseptics. We previously demonstrated that antiseptic-resistant MRSA, generated by mutation of the norA gene, are widely distributed in clinical samples. A large variety of chemical agents and antiseptics, in addition to FQs, are found in medical settings. The site of the norA mutation in mutant TP178 that was obtained in vitro was similar to that in clinical isolates. 16) Our observations therefore strongly suggest that such clinically-isolated norA mutants may have appeared in response to selective pressure from environmental chemical agents, such as antiseptics and disinfectants, rather than selective pressure from FQs. The present study has revealed the sites of norA mutations and has also suggested the possible existence of at least one other multidrug-resistance gene in S. aureus. Our results indicate that multidrug-resistant mutants of S. aureus may be generated at high frequencies in response to environmental chemicals. The two promoter regions (Ϫ35 and Ϫ10) of the norA gene are underlined. The site of initiation of transcription of the gene is boxed. The sites of mutation and nucleotide changes are indicated by arrows and the mutant is also shown in parenthesis. The SA1199B and MT23142 (flqB) mutants were isolated by Kaatz et al. 17) and Ng et al., 5) respectively. 
